Translational Cancer Pathology Lab
The main aim of the Translational Cancer Pathology Group is to better understand the determinants of short- and long-term outcomes in patients with colorectal cancer.
We are interested in the relationship between local and systemic inflammatory responses, tumour microenvironment and cell signalling with a view to taking such knowledge into the routine clinical management of colorectal cancer.
Our overarching aim is to develop novel treatment strategies to establish a personalised medicine approach for colorectal cancer.
We would like to acknowledge the generous support of our funders, past and present:
